Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$11.89 - $24.68 $177,993 - $369,459
-14,970 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$24.14 - $35.18 $651 - $949
-27 Reduced 0.18%
14,970 $372,000
Q3 2021

Nov 08, 2021

SELL
$27.38 - $42.21 $36,141 - $55,717
-1,320 Reduced 8.09%
14,997 $495,000
Q2 2021

Aug 05, 2021

BUY
$26.34 - $46.62 $270,380 - $478,554
10,265 Added 169.61%
16,317 $472,000
Q1 2021

May 05, 2021

BUY
$45.96 - $68.02 $278,149 - $411,657
6,052 New
6,052 $306,000
Q4 2020

Feb 04, 2021

SELL
$13.72 - $51.57 $456,834 - $1.72 Million
-33,297 Closed
0 $0
Q3 2020

Nov 02, 2020

SELL
$10.54 - $18.47 $158,764 - $278,213
-15,063 Reduced 31.15%
33,297 $589,000
Q2 2020

Aug 05, 2020

BUY
$10.37 - $20.64 $269,257 - $535,917
25,965 Added 115.94%
48,360 $880,000
Q1 2020

May 04, 2020

BUY
$9.63 - $17.14 $215,663 - $383,850
22,395 New
22,395 $271,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.